We compared characteristics and outcomes of breast cancer patients ( n = @ ) who participated in a randomized clinical trial ( Tamoxifen Exemestane Adjuvant Multinational trial ) with unselected breast cancer patients of corresponding age from the general population ( n = @ ) .